Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP893023.RADpKh7WuKROIe5QDMSgUZeDdwvJ_W2VdsN6C2ATfDoug130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP893023.RADpKh7WuKROIe5QDMSgUZeDdwvJ_W2VdsN6C2ATfDoug130_assertion type Assertion NP893023.RADpKh7WuKROIe5QDMSgUZeDdwvJ_W2VdsN6C2ATfDoug130_head.
- NP893023.RADpKh7WuKROIe5QDMSgUZeDdwvJ_W2VdsN6C2ATfDoug130_assertion wasGeneratedBy ECO_0000203 NP893023.RADpKh7WuKROIe5QDMSgUZeDdwvJ_W2VdsN6C2ATfDoug130_provenance.
- NP893023.RADpKh7WuKROIe5QDMSgUZeDdwvJ_W2VdsN6C2ATfDoug130_assertion wasDerivedFrom befree-2016 NP893023.RADpKh7WuKROIe5QDMSgUZeDdwvJ_W2VdsN6C2ATfDoug130_provenance.
- NP893023.RADpKh7WuKROIe5QDMSgUZeDdwvJ_W2VdsN6C2ATfDoug130_assertion SIO_000772 21558399 NP893023.RADpKh7WuKROIe5QDMSgUZeDdwvJ_W2VdsN6C2ATfDoug130_provenance.
- NP893023.RADpKh7WuKROIe5QDMSgUZeDdwvJ_W2VdsN6C2ATfDoug130_assertion evidence source_evidence_literature NP893023.RADpKh7WuKROIe5QDMSgUZeDdwvJ_W2VdsN6C2ATfDoug130_provenance.
- NP893023.RADpKh7WuKROIe5QDMSgUZeDdwvJ_W2VdsN6C2ATfDoug130_assertion description "[Patients with resectable stage I and II non-small cell lung cancer (NSCLC) enriched for the likelihood of EGFR mutation (≤ 15 pack-year cigarette smoking history and/or a component of bronchioloalveolar carcinoma) received preoperative gefitinib for 21 days.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893023.RADpKh7WuKROIe5QDMSgUZeDdwvJ_W2VdsN6C2ATfDoug130_provenance.